
NeurologyLive® Brain Games: July 26, 2026
Key Takeaways
- A Sunday-release format delivers a recurring three-question quiz built by clinicians and advocacy experts, emphasizing both clinical practice and neurology history.
- Topic coverage spans major subspecialties, including dementia/Alzheimer disease, epilepsy, headache, movement disorders, multiple sclerosis, neuromuscular and sleep disorders, and cerebrovascular disease.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is tau-targeting therapies for Alzheimer disease!
Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.
Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.
This week's questions includes the theme of tau-targeting therapies for Alzheimer disease!
Interested in submitting quiz questions? Contact our editor, Marco Meglio, via email:
Which pathological process is most directly targeted by therapies designed to inhibit tau aggregation in Alzheimer disease?
Which therapeutic approach is designed to reduce the production of tau protein by targeting MAPT mRNA?
Why is tau considered a particularly important therapeutic target in Alzheimer disease?
How did you do on this week's quiz? Let us know with a response to the poll below. Don't forget to share and compare your results with your friends!
How many questions did you get correct?

















